Alaunos Therapeutics, Inc. Share Price
NASDAQ: TCRT | Micro CapAlaunos Therapeutics, Inc. Stock Performance
Alaunos Therapeutics, Inc. Share Price Today
As of 30 October 2026, Alaunos Therapeutics, Inc.'s share price is $1.88. The stock opened at $1.95, compared to its previous close of $2.08. During today's trading session, Alaunos Therapeutics, Inc.'s share price traded between $1.87 and $2.01, with an average price of $1.94. Over the past 52 weeks, the stock has recorded a high of $4.38 and a low of $0.74. In terms of performance, Alaunos Therapeutics, Inc.'s share price has declined by 24.80% over the last six months and is down 32.13% on a year-on-year basis.
Alaunos Therapeutics, Inc. Share Price Chart
Alaunos Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Alaunos Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Alaunos Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.92 | $1.89 | +98.42% |
Sep 2026 | $1.66 | $0.95 | -44.44% |
Aug 2026 | $1.91 | $1.71 | -8.56% |
Jul 2026 | $2.27 | $1.87 | -19.05% |
Jun 2026 | $2.83 | $2.31 | -21.43% |
May 2026 | $2.88 | $2.94 | +17.60% |
Apr 2026 | $3.05 | $2.50 | -14.68% |
Mar 2026 | $3.32 | $2.93 | -6.98% |
Feb 2026 | $2.66 | $3.15 | +7.14% |
Jan 2026 | $3.25 | $2.94 | -9.54% |
Dec 2025 | $3.17 | $3.25 | -0.61% |
Nov 2025 | $2.62 | $3.27 | +18.05% |